Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Universal Health International Group Holding Ltd. ( (HK:2211) ) has shared an announcement.
Universal Health International Group Holding Limited successfully passed an ordinary resolution during its extraordinary general meeting held on January 9, 2025. The resolution involved the ratification and approval of an equity transfer agreement between Heilongjiang Jintian Aixin Pharmaceutical Distribution Limited and Huang Yanling for the purchase of a 43.78% equity interest in Jilin Jintian Universal Health Group Capsules Limited. This move, which received unanimous support, is expected to strengthen the company’s position in the pharmaceutical market, potentially benefiting its shareholders.
More about Universal Health International Group Holding Ltd.
Universal Health International Group Holding Limited is a company incorporated in the Cayman Islands with limited liability, operating in the health industry. Its primary focus is on pharmaceutical distribution, and it is listed on the Hong Kong Stock Exchange.
YTD Price Performance: -11.76%
Average Trading Volume: 14,980,445
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$120.2M
See more data about 2211 stock on TipRanks’ Stock Analysis page.